Preliminary safety results of the randomized phase II ABIDO-SOGUG trial: Toxicity profile of concomitant abiraterone acetate + docetaxel treatment in comparison to docetaxel

  1. Puente, J.
  2. Mendez Vidal, M.J.
  3. Saez, M.I.
  4. Font Pous, A.
  5. Duran, I.
  6. Castellano, D.
  7. Juan Fita, M.J.
  8. Santander, C.
  9. Arranz Arija, J.A.
  10. Sanchez-Hernandez, A.
  11. Mellado, B.
  12. Alonso, T.
  13. Gonzalez Del Alba Baamonde, M.A.
  14. Maroto, P.
  15. Lazaro, M.
  16. Esteban, E.
  17. Cassinello, J.G.
  18. Climent Duran, M.A.
Revue:
Annals of oncology : official journal of the European Society for Medical Oncology

ISSN: 1569-8041

Année de publication: 2018

Volumen: 29

Pages: viii286

Type: Article

DOI: 10.1093/ANNONC/MDY284.031 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus